[4] Zaidi N., Ahmad E., Rehan M., Rabbani G., Ajmal M.R., Zaidi Y., Subbarao N., Khan R.H.,
Biophysical Insight Into Furosemide Binding to Human Serum Albumin: A Study to Unveil its Impaired Albumin Binding in Uremia,
J. Phys. Chem. B.,
117:2595-2604 (2013).
[8] Meneyrol J., Follmann M., Lassalle G., Wehner V., Barre G., Rousseaux T., Altenburger J.M., Petit F., Bocskei Z., Schreuder H., Alet N.,
5-Chlorothiophene-2-carboxylic Acid [(S)-2-[2-Methyl-3-(2-oxopyrrolidin-1-yl) benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl] Amide (SAR107375), a Selective and Potent Orally Active Dual Thrombin and Factor Xa Inhibitor.,
J. Med. Chem.,
56:9441-9456 (2013).
[17] Tabarrini O., Manfroni G., Fravolini A., Cecchetti V., Sabatini S., De Clercq E., Rozenski J., Canard B., Dutartre H., Paeshuyse J., Neyts J.,
Synthesis and Anti-BVDV Activity of Acridones As New Potential Antiviral Agents 1,
J. Med. Chem.,
49:2621-2627 (2006).
[19] Winter R.W., Kelly J.X., Smilkstein M.J., Dodean R., Hinrichs D., Riscoe M.K.,
Antimalarial Quinolones: Synthesis, Potency, and Mechanistic Studies,
Exp. Parasitol.,
118:487-497 (2008).